## Sixty -eight patients were studied prospectively with serial thyroid-stimulating hormone (TSH) levels after radiotherapy for head and neck neoplasms. Overall, 57% of the patients developed elevated TSH levels. Excluding patients with less than 2 years follow-up, 85% developed an elevated TSH. N
Thyroid dysfunction following radiotherapy for head and neck cancer
β Scribed by S.L. Turner; K.W. Tiver; S.C. Boyages
- Publisher
- Elsevier Science
- Year
- 1995
- Tongue
- English
- Weight
- 800 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Background. Multiple oral complaints occur following radiotherapy for oropharyngeal cancer, but the frequency and severity of symptoms of dysfunction and discomfort are not well understood. The purpose of this investigation was to assess the quality of life, oral function, and oral symptoms followin
Radiotherapy for benign conditions of the head and neck area was first linked to thyroid carcinoma in 1950. All the salivary glands, the parathyroids, and the facial skin can also develop neoplastic lesions in this setting. Thyroid carcinoma is most commonly papillary or mixed papillary and follicul
## Abstract ## Background The purpose of this study was to investigate the incidence of radiotherapyβinduced primary and secondary hypopituitarism. ## Methods Three hundred twelve patients treated with radiotherapy for extracranial head and neck tumors between 1964 and 2000 were evaluated. Radio
## Abstract ## Background. The purpose of this study was to evaluate the use of intraoperative electron beam radiotherapy (IORT) as an adjuvant modality in the treatment of advanced head and neck and skull base cancer. ## Methods. Between 1991 and 1996, 34 patients with squamous cell carcinoma (